Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy.

Saracino A, Zaccarelli M, Lorenzini P, Bandera A, Marchetti G, Castelli F, Gori A, Girardi E, Mussini C, Bonfanti P, Ammassari A, d'Arminio Monforte A; Icona Foundation Study Group.

BMC Public Health. 2018 Jul 13;18(1):870. doi: 10.1186/s12889-018-5804-z.

2.

Cross-talk between human airway epithelial cells and 3T3-J2 feeder cells involves partial activation of human MET by murine HGF.

Hynds RE, Gowers KHC, Nigro E, Butler CR, Bonfanti P, Giangreco A, Prêle CM, Janes SM.

PLoS One. 2018 May 17;13(5):e0197129. doi: 10.1371/journal.pone.0197129. eCollection 2018.

3.

Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.

Bagella P, De Socio GV, Ricci E, Menzaghi B, Martinelli C, Squillace N, Maggi P, Orofino G, Calza L, Carenzi L, Celesia BM, Penco G, Di Biagio A, Valsecchi L, Vichi F, Colombo V, Parruti G, Dentone C, Falasca K, Bonfanti P, Madeddu G; C.I.S.A.I. Study Group, Italy.

Infect Drug Resist. 2018 Apr 26;11:615-623. doi: 10.2147/IDR.S152090. eCollection 2018.

4.

A glyphosate micro-emulsion formulation displays teratogenicity in Xenopus laevis.

Bonfanti P, Saibene M, Bacchetta R, Mantecca P, Colombo A.

Aquat Toxicol. 2018 Feb;195:103-113. doi: 10.1016/j.aquatox.2017.12.007. Epub 2017 Dec 24.

PMID:
29306033
5.

Regenerating human epithelia with cultured stem cells: feeder cells, organoids and beyond.

Hynds RE, Bonfanti P, Janes SM.

EMBO Mol Med. 2018 Feb;10(2):139-150. doi: 10.15252/emmm.201708213. Review.

6.

Streptococcus agalactiae infective endocarditis complicated by multiple mycotic hepatic aneurysms and massive splenic infarction: a case report.

Achilli P, Guttadauro A, Bonfanti P, Terragni S, Fumagalli L, Cioffi U, Gabrielli F, De Simone M, Chiarelli M.

BMC Gastroenterol. 2017 Dec 29;17(1):170. doi: 10.1186/s12876-017-0728-0.

7.

Weight Gain: A Possible Side Effect of All Antiretrovirals.

Taramasso L, Ricci E, Menzaghi B, Orofino G, Passerini S, Madeddu G, Martinelli CV, De Socio GV, Squillace N, Rusconi S, Bonfanti P, Di Biagio A; CISAI Study Group .

Open Forum Infect Dis. 2017 Nov 3;4(4):ofx239. doi: 10.1093/ofid/ofx239. eCollection 2017 Fall.

8.

Awareness of medical radiation exposure among patients: A patient survey as a first step for effective communication of ionizing radiation risks.

Ria F, Bergantin A, Vai A, Bonfanti P, Martinotti AS, Redaelli I, Invernizzi M, Pedrinelli G, Bernini G, Papa S, Samei E.

Phys Med. 2017 Nov;43:57-62. doi: 10.1016/j.ejmp.2017.10.014. Epub 2017 Oct 31.

PMID:
29195563
9.

High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity.

Mingione A, Maruca K, Chiappori F, Pivari F, Brasacchio C, Quirino T, Merelli I, Soldati L, Bonfanti P, Mora S.

Biomed Pharmacother. 2018 Jan;97:969-974. doi: 10.1016/j.biopha.2017.11.037. Epub 2017 Nov 7.

PMID:
29136775
10.

Mother-to-child transmission of KPC-producing Klebsiella pneumoniae: potential relevance of a low microbial urinary load for screening purposes.

Principe L, Meroni E, Conte V, Mauri C, Di Pilato V, Giani T, Bonfanti P, Rossolini GM, Luzzaro F.

J Hosp Infect. 2018 Mar;98(3):314-316. doi: 10.1016/j.jhin.2017.10.008. Epub 2017 Oct 16. No abstract available.

PMID:
29042234
11.

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients.

Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D.

Ther Clin Risk Manag. 2017 Jun 29;13:787-797. doi: 10.2147/TCRM.S135972. eCollection 2017.

12.

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project.

Squillace N, Ricci E, Quirino T, Gori A, Bandera A, Carenzi L, De Socio GV, Orofino G, Martinelli C, Madeddu G, Rusconi S, Maggi P, Celesia BM, Cordier L, Vichi F, Calza L, Falasca K, Di Biagio A, Pellicanò GF, Bonfanti P; CISAI Study Group.

PLoS One. 2017 Jun 20;12(6):e0179254. doi: 10.1371/journal.pone.0179254. eCollection 2017.

13.

Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

Taramasso L, Ricci E, Celesia BM, Bonfanti P, Quirino T, Squillace N, Nicolini LA, Maggi P, Martinelli C, De Socio GV, Di Biagio A; on behalf CISAI Study Group.

Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):e76-e79. doi: 10.1016/j.clinre.2017.03.006. Epub 2017 Apr 21. No abstract available.

PMID:
28438572
14.

Teratogenic hazard of BPEI-coated silver nanoparticles to Xenopus laevis.

Colombo A, Saibene M, Moschini E, Bonfanti P, Collini M, Kasemets K, Mantecca P.

Nanotoxicology. 2017 Apr;11(3):405-418. doi: 10.1080/17435390.2017.1309703.

PMID:
28318347
15.

Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir.

Bonfanti P, Madeddu G, Gulminetti R, Squillace N, Orofino G, Vitiello P, Rusconi S, Celesia BM, Maggi P, Ricci E; CISAI Study group.

AIDS. 2017 Jan 28;31(3):455-457. doi: 10.1097/QAD.0000000000001351. No abstract available.

PMID:
28079544
16.

HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy.

Croce D, Lazzarin A, Rizzardini G, Gianotti N, Scolari F, Foglia E, Garagiola E, Ricci E, Bini T, Quirino T, Viganò P, Re T, D'Arminio Monforte A, Bonfanti P.

PLoS One. 2016 Dec 28;11(12):e0168399. doi: 10.1371/journal.pone.0168399. eCollection 2016.

17.

Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study.

De Socio GV, Ricci E, Maggi P, Parruti G, Celesia BM, Orofino G, Madeddu G, Martinelli C, Menzaghi B, Taramasso L, Bonfanti P, Pucci G, Schillaci G; CISAI study group.

J Hypertens. 2017 Feb;35(2):409-416. doi: 10.1097/HJH.0000000000001150.

PMID:
28005710
18.

Mother-To-Child Transmission of KPC Carbapenemase-Producing Klebsiella Pneumoniae at Birth.

Bonfanti P, Bellù R, Principe L, Caramma I, Condò M, Giani T, Rossolini GM, Luzzaro F.

Pediatr Infect Dis J. 2017 Feb;36(2):228-229. doi: 10.1097/INF.0000000000001403.

PMID:
27846056
19.

Knowledge transfer: what drug information would specialist doctors need to support their clinical practice? Results of a survey and of three focus groups in Italy.

Formoso G, Rizzini P, Bassi M, Bonfanti P, Rizzardini G, Campomori A, Mosconi P.

BMC Med Inform Decis Mak. 2016 Sep 1;16:115. doi: 10.1186/s12911-016-0355-7.

20.

The zinc finger transcription factor PW1/PEG3 restrains murine beta cell cycling.

Sojoodi M, Stradiot L, Tanaka K, Heremans Y, Leuckx G, Besson V, Staels W, Van de Casteele M, Marazzi G, Sassoon D, Heimberg H, Bonfanti P.

Diabetologia. 2016 Jul;59(7):1474-1479. doi: 10.1007/s00125-016-3954-z. Epub 2016 Apr 29.

21.

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.

De Socio GV, Ricci E, Parruti G, Calza L, Maggi P, Celesia BM, Orofino G, Madeddu G, Martinelli C, Menzaghi B, Taramasso L, Penco G, Carenzi L, Franzetti M, Bonfanti P.

Infection. 2016 Oct;44(5):589-97. doi: 10.1007/s15010-016-0893-z. Epub 2016 Apr 5.

PMID:
27048184
22.

Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.

Saracino A, Lorenzini P, Lo Caputo S, Girardi E, Castelli F, Bonfanti P, Rusconi S, Caramello P, Abrescia N, Mussini C, Monno L, d'Arminio Monforte A; ICONA Foundation Study Group.

Clin Microbiol Infect. 2016 Mar;22(3):288.e1-8. doi: 10.1016/j.cmi.2015.10.026. Epub 2015 Nov 10.

23.

Multiple Pill Regimens, Single Tablet Regimens and Hiv+ Patients Quality of Life: Evidence from the Straq Study.

Foglia E, Maggiolo F, Quirino T, Bonfanti P, Scolari F, Garagiola E, Ferrario L, Bernasconi D, Croce D.

Value Health. 2015 Nov;18(7):A591. doi: 10.1016/j.jval.2015.09.1521. Epub 2015 Oct 20. No abstract available.

24.

Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?

Nicolini LA, Menzaghi B, Ricci E, Martinelli C, Magni C, Maggi P, Celesia BM, Parruti G, Babudieri S, Bonfanti P, Falasca K, Vichi F, De Socio GV, Salomoni E, Di Biagio A, Quirino T.

Eur J Gastroenterol Hepatol. 2016 Jan;28(1):37-41. doi: 10.1097/MEG.0000000000000483.

PMID:
26460621
25.

A new method to evaluate the residual activity in patients undergoing (131)I thyroid therapy.

Ostinelli A, Duchini M, Conti V, Bonfanti P, Rossi S, Cacciatori M.

Phys Med. 2015 Dec;31(8):1108-1111. doi: 10.1016/j.ejmp.2015.08.012. Epub 2015 Oct 1.

PMID:
26429386
26.

Decrease of renal function in HCV and HIV/HCV-infected patients with telaprevir-based therapy.

Prinapori R, Ricci E, Menzaghi B, Borghi V, Maggi P, Martinelli C, Magni C, Parruti G, Bonfanti P, Mussini C, Di Biagio A; CISAI and Modena Cohort.

AIDS. 2015 Sep 24;29(15):2061-2. doi: 10.1097/QAD.0000000000000785. No abstract available.

PMID:
26352883
27.
28.

Do Nanoparticle Physico-Chemical Properties and Developmental Exposure Window Influence Nano ZnO Embryotoxicity in Xenopus laevis?

Bonfanti P, Moschini E, Saibene M, Bacchetta R, Rettighieri L, Calabri L, Colombo A, Mantecca P.

Int J Environ Res Public Health. 2015 Jul 28;12(8):8828-48. doi: 10.3390/ijerph120808828.

29.

Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.

Bandera A, Gori A, Sabbatini F, Madeddu G, Bonora S, Libertone R, Mastroianni C, Bonfanti P, d'Arminio Monforte A, Cozzi-Lepri A; Icona Foundation Study Group.

PLoS One. 2015 May 1;10(5):e0124252. doi: 10.1371/journal.pone.0124252. eCollection 2015.

30.

Ex Vivo Expansion and Differentiation of Human and Mouse Fetal Pancreatic Progenitors Are Modulated by Epidermal Growth Factor.

Bonfanti P, Nobecourt E, Oshima M, Albagli-Curiel O, Laurysens V, Stangé G, Sojoodi M, Heremans Y, Heimberg H, Scharfmann R.

Stem Cells Dev. 2015 Aug 1;24(15):1766-78. doi: 10.1089/scd.2014.0550. Epub 2015 Jun 8.

PMID:
25925840
31.

Toxicity Evaluation of a New Zn-Doped CuO Nanocomposite With Highly Effective Antibacterial Properties.

Mantecca P, Moschini E, Bonfanti P, Fascio U, Perelshtein I, Lipovsky A, Chirico G, Bacchetta R, Del Giacco L, Colombo A, Gedanken A.

Toxicol Sci. 2015 Jul;146(1):16-30. doi: 10.1093/toxsci/kfv067. Epub 2015 Mar 26.

PMID:
25820130
32.

Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals.

Taramasso L, Madeddu G, Ricci E, De Socio GV, Menzaghi B, Orofino G, Passerini S, Franzetti M, Maggi P, Dentone C, Martinelli C, Celesia BM, Penco G, Libertone R, Quirino T, Bonfanti P, Di Biagio A; CISAI Study Group.

Biomed Pharmacother. 2015 Feb;69:233-6. doi: 10.1016/j.biopha.2014.12.006. Epub 2014 Dec 12.

PMID:
25661363
33.

Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.

Madeddu G, De Socio GV, Ricci E, Quirino T, Orofino G, Carenzi L, Franzetti M, Parruti G, Martinelli C, Vichi F, Penco G, Dentone C, Celesia BM, Maggi P, Libertone R, Bagella P, Di Biagio A, Bonfanti P; C.I.S.A.I. Group, Italy.

Int J Antimicrob Agents. 2015 Mar;45(3):289-94. doi: 10.1016/j.ijantimicag.2014.10.013. Epub 2014 Nov 13.

PMID:
25476452
34.

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.

Saracino A, Lorenzini P, Lo Caputo S, Girardi E, Castelli F, Bonfanti P, Galli M, Caramello P, Abrescia N, Mussini C, Monno L, Monforte Ad.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19769. doi: 10.7448/IAS.17.4.19769. eCollection 2014.

35.

Conservation tillage affects species composition but not species diversity: a comparative study in Northern Italy.

Boscutti F, Sigura M, Gambon N, Lagazio C, Krüsi BO, Bonfanti P.

Environ Manage. 2015 Feb;55(2):443-52. doi: 10.1007/s00267-014-0402-z. Epub 2014 Nov 13.

PMID:
25392019
36.

Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study.

Gianotti N, Poli A, Galli M, Pan A, Rizzardini G, Soria A, Viale P, Di Biagio A, Quirino T, Viganò P, Bonfanti P, d'Arminio Monforte A, Fortino I, Lazzarin A.

New Microbiol. 2014 Oct;37(4):439-48. Epub 2014 Oct 1.

37.

Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF, Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d'Arminio Monforte A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M, Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E, Taliani G.

New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1.

38.

Assessing access to MRI of patients with magnetic resonance-conditional pacemaker and implantable cardioverter defibrillator systems: the Really ProMRI study design.

Maglia G, Curnis A, Brieda M, Anaclerio M, Caccavo V, Bonfanti P, Melissano D, Caravati F, Giovene L, Gargaro A; Really ProMRI Study Group.

J Cardiovasc Med (Hagerstown). 2015 Oct;16(10):715-20. doi: 10.2459/JCM.0000000000000186.

PMID:
25252037
39.

Novel antiretroviral drugs and renal function monitoring of HIV patients.

Maggi P, Montinaro V, Mussini C, Di Biagio A, Bellagamba R, Bonfanti P, Calza L, Cherubini C, Corsi P, Gargiulo M, Montella F, Rusconi S.

AIDS Rev. 2014 Jul-Sep;16(3):144-51. Review.

PMID:
25102336
40.

The problem of renal function monitoring in patients treated with the novel antiretroviral drugs.

Maggi P, Montinaro V, Rusconi S, Di Biagio A, Bellagamba R, Bonfanti P, Calza L, Corsi P, Montella F, Mussini C.

HIV Clin Trials. 2014 May-Jun;15(3):87-91. doi: 10.1310/hct1503-87.

41.

Lineage potential, plasticity and environmental reprogramming of epithelial stem/progenitor cells.

Amici AW, Onikoyi FO, Bonfanti P.

Biochem Soc Trans. 2014 Jun;42(3):637-44. doi: 10.1042/BST20140047. Review.

PMID:
24849231
42.

Gender differences in HIV infection: is there a problem? Analysis from the SCOLTA cohorts.

Menzaghi B, Ricci E, Vichi F, De Sociod GV, Carenzi L, Martinelli C, Franzetti M, Orofino G, Madeddu G, Parruti G, Penco G, Grosso C, Di Biagio A, Bonfanti P, Quirino T; CISAI Study Group.

Biomed Pharmacother. 2014 Apr;68(3):385-90. doi: 10.1016/j.biopha.2014.01.007. Epub 2014 Feb 12.

PMID:
24613008
43.

Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort.

Cingolani A, Cozzi-Lepri A, Ammassari A, Mussini C, Ursitti MA, Caramello P, Angarano G, Bonfanti P, De Luca A, Mura MS, Girardi E, Antinori A, Monforte AD; Icona Foundation Study group.

PLoS One. 2014 Feb 27;9(2):e89861. doi: 10.1371/journal.pone.0089861. eCollection 2014.

44.

Isolated acute dysphagia due to varicella-zoster virus.

Mantero V, Rigamonti A, Valentini S, Fiumani A, Piamarta F, Bonfanti P, Salmaggi A.

J Clin Virol. 2014 Apr;59(4):268-9. doi: 10.1016/j.jcv.2014.01.008. Epub 2014 Jan 25.

PMID:
24529416
45.

Prospectively isolated NGN3-expressing progenitors from human embryonic stem cells give rise to pancreatic endocrine cells.

Cai Q, Bonfanti P, Sambathkumar R, Vanuytsel K, Vanhove J, Gysemans C, Debiec-Rychter M, Raitano S, Heimberg H, Ordovas L, Verfaillie CM.

Stem Cells Transl Med. 2014 Apr;3(4):489-99. doi: 10.5966/sctm.2013-0078. Epub 2014 Feb 3.

46.

Decreasing cardiovascular risk in HIV infection between 2005 and 2011.

De Socio GV, Parruti G, Ricci E, Maggi P, Celesia BM, Penco G, Martinelli C, Franzetti M, Di Biagio A, Bonfanti P, Pucci G, Schillaci G; CISAI study group.

AIDS. 2014 Feb 20;28(4):609-12. doi: 10.1097/QAD.0000000000000181.

PMID:
24378754
47.

Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice.

Baeyens L, Lemper M, Leuckx G, De Groef S, Bonfanti P, Stangé G, Shemer R, Nord C, Scheel DW, Pan FC, Ahlgren U, Gu G, Stoffers DA, Dor Y, Ferrer J, Gradwohl G, Wright CV, Van de Casteele M, German MS, Bouwens L, Heimberg H.

Nat Biotechnol. 2014 Jan;32(1):76-83. doi: 10.1038/nbt.2747. Epub 2013 Nov 17.

48.

Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis.

Huch M, Bonfanti P, Boj SF, Sato T, Loomans CJ, van de Wetering M, Sojoodi M, Li VS, Schuijers J, Gracanin A, Ringnalda F, Begthel H, Hamer K, Mulder J, van Es JH, de Koning E, Vries RG, Heimberg H, Clevers H.

EMBO J. 2013 Oct 16;32(20):2708-21. doi: 10.1038/emboj.2013.204. Epub 2013 Sep 17.

49.

Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting.

d'Arminio Monforte A, Gianotti N, Cozzi-Lepri A, Pinnetti C, Andreoni M, di Perri G, Galli M, Poli A, Costantini A, Orofino G, Maggiolo F, Mazzarello G, Celesia BM, Luciani F, Lazzarin A, Sighinolfi L, Rizzardini G, Bonfanti P, Perno CF, Antinori A; ICONA Foundation Cohort.

Antivir Ther. 2014;19(3):319-24. doi: 10.3851/IMP2687. Epub 2013 Sep 13.

PMID:
24036891
50.

Incidence, timing, and determinants of bacterial pneumonia among HIV-infected patients: data from the ICONA Foundation Cohort.

Mussini C, Galli L, Lepri AC, De Luca A, Antinori A, Libertone R, Angarano G, Bonfanti P, Castagna A, DʼArminio Monforte A; ICONA Foundation Study Group.

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):339-45. doi: 10.1097/QAI.0b013e318295ab85.

PMID:
23591636

Supplemental Content

Loading ...
Support Center